| Literature DB >> 24403908 |
Jeroen S Kok1, Ina J Berg1, Erik J A Scherder2.
Abstract
BACKGROUND: Special care facilities for patients with dementia gain increasing attention. However, an overview of studies examining the differences between care facilities with respect to their effects on behavior, cognition, functional status and quality of life is lacking.Entities:
Keywords: Behavior; Cognition; Dementia; Functional status; Nursing home; Quality of life; Special care units
Year: 2013 PMID: 24403908 PMCID: PMC3884203 DOI: 10.1159/000353441
Source DB: PubMed Journal: Dement Geriatr Cogn Dis Extra ISSN: 1664-5464
BPSD, effect sizes and p values
| First author | Design | SCU vs. n-SCU, n | Results | Assessment instrument | p value | Cohen's d (baseline) |
|---|---|---|---|---|---|---|
| De Rooij [ | quasi-experimental, longitudina | 51 vs. 51 | – social engagement | NPI [ | <0.01 | not available |
| – depression | n.s. | |||||
| – behavioral problems | n.s. | |||||
| 30 vs. 47 | – social engagement | n.s. | ||||
| – depression | <0.10 | |||||
| – behavioral problems | n.s. | |||||
| Abrahamson [ | Interviews, random, cross-sectional | 665 vs. 12,442 | – depression – anxiety | MDS [ | 0.743 0.029 | not available |
| Nazir [ | cohort study | 2,843 vs. 23,322 | – worsening behavior | MDS | <0.001 | not available |
| – more verbally abusive | 0.399 | |||||
| – more physically abusive | 0.049 | |||||
| – more socially | 0.063 | |||||
| inappropriate | <0.001 | |||||
| – growing resistance to care | ||||||
| Verbeek [ | quasi-experimental, longitudinal, controlled | 124 vs. 135 | – neuropsychiatry | NPI | n.s. | 0.04 |
| – agitation | CMAI-D [ | 0.035 | −0.02 | |||
| Weyerer [ | cross-sectional, randomly selected, matched | 594 vs. 573 | – neuropsychiatry | NPI | n.s. | 0.07 |
| – agitation | CMAI [ | <0.001 | 0.38 | |||
| Te Boekhorst [ | quasi-experimental, longitudinal, matched, controlled | 67 vs. 97 | – depression | RMBPC [ | n.s. | not available |
| – behavior | n.s. | |||||
| – neuropsychiatry | NPI | n.s. | ||||
| – social engagement | RISE [ | <0.05 | ||||
| Selbaek [ | cross-sectional | 313 vs. 762 | – delusions | NPI | ≥0.001 | not available |
| – hallucination | ≥0.001 | |||||
| – depression | n.s. | |||||
| – anxiety | ≥0.01 | |||||
| – euphoria | ≥0.001 | |||||
| – agression/agitation | ≥0.001 | |||||
| – apathy | n.s. | |||||
| – disinhibition | n.s. | |||||
| – aberrant motor behavior | ≥0.01 | |||||
| Nobili [ | longitudinal comparative | 72 vs. 72 | – neuropsychiatry | NPI | 0.0001 | −0.74 |
| Pekkarinen [ | cross-sectional | 390 vs. 587 | – behavioral problems | LRAI [ | <0.001 | 1.16 |
| Morgan [ | experimental, cross-sectional | 186 vs. 169 | – exposure to disruptive behavior | EDB [ | <0.01 | −0.028 |
| EAC [ | <0.05 | −0.027 | ||||
| – exposure to aggression | ||||||
| Sloane [ | cross-sectional, random | 773 vs. 479 | – behavioral problems | CMAI | n.s. | -0.001 |
| – depressive symptom | Cornell [ | 0.001 | 0.007 | |||
| – social functioning | no standardized | 0.001 | 0.012 | |||
| – social withdrawal | instrument | 0.001 | −0.015 | |||
| MOSES [ | ||||||
| Reimer [ | matched groups | 62 vs. 59 | – agitation | CMAI | n.s. | not available |
| – social withdrawal | MOSES | n.s. | ||||
| – affect (anxiety) | AARS [ | n.s. | ||||
| – socially appropriate | Pleasant Events | n.s. | ||||
| behavior | scale [ | |||||
| Warren [ | longitudinal, controlled | 44 vs. 36 | – depression | Cornell | not | −0.06 |
| – psychosocial functioning | MOSES | available | 1.82 | |||
| Chappel [ | experimental, longitudinal, controlled | total: 323 | – agitation | CMAI | n.s. | not available |
| – social skills | MAS-R [ | <0.05 | ||||
| – affect | FTQ | n.s. | ||||
| Leon [ | experimental field study | 432 vs. 164 | – aggressive behavior | CMAI | n.s. | 0.05 |
| – disruptive behavior | MDS | <0.01 | 0.24 | |||
| Frisoni [ | longitudinal, controlled | 31 vs. 35 | – delusions | NPI | not available | 0.33 |
| – hallucinations | 0.44 | |||||
| – agitation | 0.46 | |||||
| – anxiety | 0.27 | |||||
| – euphoria/elation | −0.07 | |||||
| – disinhibition | 0.12 | |||||
| – irritability/lability | 0.42 | |||||
| – abberant motor behavior | 0.18 | |||||
| – sleep | 0.20 | |||||
| – total neuropsychiatry | 0.64 | |||||
| – agitation | CMAI | 0.49 | ||||
| – depression | Cornell | 1.05 | ||||
| Saxton [ | longitudinal, matched, controlled | 26 vs. 19 | – social/cognitive | NHBPS [ | n.s. | 0.56 |
| Kovach [ | behavioral observations | 23 vs. 14 | – functional behavior | no standardized instrument | not available | −0.50 |
| Swanson [ | quasi-experimental, longitudinal | 13 vs. 9 | – noncognitive behavior | ADAS [ | n.s. | 0.65 |
| Lindesay [ | cross-sectional | 27 vs. 29 | – depression | DSS [ | not available | 0.11 |
| – activity disturbance | ABRS [ | 0.28 | ||||
| – aggressivity | −0.21 | |||||
| Chafetz [ | quasi-experimental, longitudinal | 12 vs. 8 | – behavior | BRF [ | n.s. | not available |
| Holmes [ | quasi-experimental, longitudinal | 49 vs. 44 | – disturbing behavior total | INCARE [ | n.s. | 0.47 |
| score | n.s. | 0.36 | ||||
| – depression | 0.01 | −0.36 | ||||
| – social activities | ||||||
MDS = Minimum data set 2.0 section E4; NPI = Neuropsychiatric Inventory; CMAI(-D) = Cohen-Mansfield Agitation Inventory (-Dutch version); RMBPC = Revised Memory and Behaviour Problems Checklist; RISE = Revised Index of Social Engagement from the Resident Assessment Instrument (RAI); LRAI = Long-Term Care Resident Assessment Instrument; EDB = Exposure to Disruptive Behaviours subscale; EAC = Exposure to Aggression during Caregiving subscale; Cornell = Cornell Scale for Depression in Dementia; MOSES = Multidimensional Observation Scale for Elderly Subjects; AARS = Apparent Affect Rating Scale; MAS-R = Multifocus Assessment Scale-Revised; FTQ = Feeling Tone Questionnaire (no statistics available on research initiation); NHBPS = Nursing Home Behavioral Problem Scale; ADAS = Alzheimer's Disease Assessment Scale; DSS = Depressive Signs Scale; ABRS = Adaptive Behaviour Rating Scale; BRF = Behaviour Rating Form; INCARE = Institutional Comprehensive Assessment and Referral Evaluation; n.s. = not significant.
Over time;
17 items of participation in social activities;
checklist for behavioural mapping in long-term care facilities;
small-scale, homelike SCU/SCU comparison;
small-scale, homelike SCU/n-SCU comparison;
SCU/n-SCU with mixed-sex population.
Cognition, effect sizes and p values
| First author | Design | SCU vs. n-SCU, n | Results | Assessment instrument | p value | Cohen's d (baseline) |
|---|---|---|---|---|---|---|
| De Rooij [ | quasi-experimental, longitudinal | 51 vs. 51 | – cognition | MMSE [ | not available | −0.45 |
| 30 vs. 47 | – cognition | 0.31 | ||||
| Abrahamson [ | random, cross-sectional | 665 vs. 12,442 | – cognitive impairment | CPS [ | <0.001 | 1.02 |
| Nazir [ | cohort study | 2,843 vs. 23,322 | – cognitive impairment | CPS | <0.001 | 0.96 |
| Verbeek [ | quasi-experimental, longitudinal, controlled | 124 vs. 135 | – cognition | MMSE | n.s. | 0.09 |
| Verbeek [ | cross-sectional | 586 vs. 183 | – cognition | CPS/MDS [ | n.s. | 11.76 |
| Te Boekhorst [ | quasi-experimental, longitudinal, matched, controlled | 67 vs. 97 | – cognitive functioning | MMSE | n.s. | not available |
| – memory | RMBPC [ | n.s. | ||||
| Nobili [ | longitudinal, comparative | 72 vs. 72 | – cognitive performance | MMSE | n.s. | 0.72 |
| Pekkarinen [ | cross-sectional, selection by characteristics | 390 vs. 587 | – cognition | CPS | <0.001 | 1.24 |
| Sloane [ | cross-sectional, random | 773 vs. 479 | – cognitive status | MDS-COGS [ | 0.005 | −0.007 |
| Warren [ | longitudinal, controlled | 44 vs. 36 | – cognitive status | MMSE | not available | −1.96 |
| Chappel [ | experimental | total: 323 | – cognitive functioning | MAS-R [ | n.s. | 0.009 |
| – expressive language skills | <0.01 | 0.156 | ||||
| Leon [ | experimental field study | 432 vs. 164 | – cognitive limitations | MDS-COGS | <0.001 | 0.31 |
| McAllister [ | cross-sectional | 59 vs. 34 | – cognitive functioning | MMSE | not available | 0.01 |
| Frisoni [ | controlled study | 31 vs. 35 | – cognitive status | MMSE | n.s. | −0.20 |
| – memory loss | CDR [ | n.s. | 0.03 | |||
| Saxton [ | longitudinal, matched, controlled | 26 vs. 19 | – mental status | MMSE | n.s. | −0.04 |
| Kovach [ | behavioral observations/tests | 23 vs. 14 | – mental status | MMSE | not available | 0.52 |
| Volicer [ | prospective cohort study | 50 vs. 112 | – cognitive impairment | MMSE | <0.05 | −0.10 |
| – speech | BADE [ | n.s. | 0.05 | |||
| Swanson [ | quasi-experimental design, pre-/post-tests | 13 vs. 9 | – cognitive behavior | ADAS [ | n.s. | 1.12 |
| Lindesay [ | cross-sectional | 27 vs. 29 | – cognitive impairment | OBS [ | not available | −0.67 |
| – communication | ABRS [ | 0.93 | ||||
| – recognition | 1.33 | |||||
| – orientation | 0.29 | |||||
| Chafetz [ | quasi-experimental, longitudinal | 12 vs. 8 | – cognitive ability | DRS [ | n.s. | not available |
| Holmes [ | quasi-experimental | 49 vs. 44 | – dementia scale | K-GMSQ [ | 0.05 | 0.52 |
| Coleman [ | experimental | 47 vs. 36 | – cognitive decline | RGDS [ | <0.01 | not available |
CPS = Cognitive Performance Scale; RMBPC = Revised Memory and Behaviour Problems Checklist; MDS-COGS = Minimum Data Set Cognitive Performance Scale; MAS-R = Multifocus Assessment Scale-Revised; CDR = Clinical Dementia Rating Scale; BADE = Boston Aphasia Diagnostic Evaluation; ADAS = Alzheimer's Disease Assessment Scale; OBS = Organic Brain Syndrome scale; CARE = subscale of the Comprehensive Assessment and Referral Evaluation; ABRS = Adaptive Behaviour Rating Scale; DRS = Mattis Dementia Rating Scale; K-GMSQ = Kahn-Goldfarb Mental Status Questionnaire; RGDS = Reisberg Global Deterioration Scale; n.s. = not significant.
Over time;
follow-up measurement;
small-scale, homelike SCU/SCU comparison;
small-scale, homelike SCU/n-SCU comparison;
SCU/n-SCU with mixed-sex population.
Functional status/ADL, effect sizes and p values
| Author | Design | SCU vs. n-SCU, n | Results | Assessment instrument | p value | Cohen's d (baseline) |
|---|---|---|---|---|---|---|
| Orfaly Cadigan [ | longitudinal, controlled | 141 vs. 31 | – functional status | BANS-S [ | 0.0001 | not available |
| De Rooij [ | quasi-experimental, longitudinal | 51 vs. 51 | – functional status | Barthel index [ | not available | −0.58 |
| 30 vs. 47 | −0.53 | |||||
| Abrahamson [ | random, cross-sectional | 665 vs. 12,442 | – functional level | MDS ADL [ | 0.433 | 0.03 |
| Verbeek [ | quasi-experimental, longitudinal, controlled | 124 vs. 135 | – ADL | ADL-H [ | n.s. | −0.13 |
| Verbeek [ | cross-sectional | 586 vs. 183 | – functional status | MDS [ | n.s. | 10.72 |
| Weyerer [ | cross-sectional, randomly selected, matched | 594 vs. 573 | – ADL | Barthel index | <0.05 | −0.12 |
| Te Boekhorst [ | quasi-experimental, longitudinal, controlled | 67 vs. 97 | – ADL | IDDD [ | <0.01 | not available |
| Nobili [ | longitudinal, comparative | 72 vs. 72 | – functional status | Barthel index | 0.0005 | 0.56 |
| Pekkarinen [ | cross-sectional, selection by characteristics | 390 vs. 587 | – assistance in ADL | MDS ADL | 0.05 | 0.46 |
| Ashcraft [ | cross-sectional | 15 vs. 15 | – ADL | MDS ADL | not available | −0.30 |
| Sloane [ | cross-sectional, random | 773 vs. 479 | – ADL impairment | MDS ADL | 0.001 | −0.021 |
| Reimer [ | matched groups design | 62 vs. 59 | – functional status | FAST [ | 0.016 | not available |
| Luo [ | cross-sectional | 750 vs. 3,667 | – ADL | no standardized instrument | >0.01 | −5.70 |
| Warren [ | longitudinal, controlled | 44 vs. 36 | – physical status (ADL) | FAM + FIM [ | not available | −2.30 |
| Chappel [ | experimental | total: 323 | – physical functioning | MDS ADL | <0.01 | 0.176 |
| Leon [ | experimental field study | 432 vs. 164 | – ADL limitations | MDS ADL | n.s. | 0.07 |
| Frisoni [ | longitudinal, controlled | 31 vs. 35 | – function | Barthel index | not available | 0.31 |
| Saxton [ | longitudinal, matched, controlled | 26 vs. 19 | – total ADL | FIM | n.s. | 5.5 |
| – self-care | <0.05 | 0.11 | ||||
| Phillips [ | longitudinal, matched, controlled | 1,228 vs. 5,904 vs. 70,205 | – ADL function | MDS ADL | n.s. | not available |
| Volicer [ | prospective cohort study | 50 vs. 112 | – ADL | Katz ADL index [91 | n.s. | 0.01 |
| Swanson [ | quasi-experimental, pre-/post-tests | 13 vs. 9 | – functional ability I | FAC/ GRS [ | n.s.* | 0.45 |
| – functional ability II | n.s.* | 0.03 | ||||
| Lindesay [ | cross-sectional | 27 vs. 29 | – dressing | ABRS [ | not available | 0.71 |
| – washing | 1.02 | |||||
| – feeding | 0.36 | |||||
| – toileting | 0.41 | |||||
| – mobility | 0.32 | |||||
| Chafetz [ | quasi-experimental, longitudinal | 12 vs. 8 | – ADL | Katz ADL index | n.s. | not available |
| Holmes [ | quasi-experimental | 49 vs. 44 | – ADL | Katz ADL index | n.s. | 0.15 |
| Coleman [ | experimental | 47 vs. 36 | – ADL functional level | Katz ADL index | <0.01 | not available |
MDS ADL = Morris scale; IDDD = Interview for the Deterioration of Daily Living Activities in Dementia; ADL-H = MDS; FAC = Functional Ability Checklist; GRS = Assessment Functioning of Geriatric Patients; ABRS = Adaptive Behaviour Rating Scale; BANS-S = Bedford Alzheimer's Nursing Severity-Subscale; n.s. = not significant.
Over time;
ADLs dependence was measured by the degree of dependence in five ADL (transferring, eating, toileting, dressing, bathing);
small-scale, homelike SCU/SCU comparison;
small-scale, homelike/n-SCU comparison;
SCU/n-SCU with mixed-sex population.
Quality of life and remaining variables, effect sizes and p values
| Author | Design | SCU vs. n-SCU, n | Results | Assessment instrument | p value | Cohen's d (baseline) |
|---|---|---|---|---|---|---|
| De Rooij [ | quasi-experimental, longitudinal | 51 vs. 51 | – positive affect | QUALIDEM [ | <0.001 | not available |
| – negative affect | n.s. | |||||
| – social relations | <0.001 | |||||
| – social isolation | n.s. | |||||
| – restless behavior | n.s. | |||||
| 30 vs. 47 | – positive affect | n.s. | ||||
| – negative affect | <0.01 | |||||
| – social relations | n.s. | |||||
| – social isolation | n.s. | |||||
| – restless behavior | n.s. | |||||
| Abrahamson [ | interviews, random, cross-sectional | 665 vs. 12,442 | – comfort | NHQL | 0.007 | 0.11 |
| – activity | 0.023 | 0.00 | ||||
| – privacy | 0.198 | −0.06 | ||||
| – environment | <0.001 | 0.18 | ||||
| – individuality | 0.495 | −0.03 | ||||
| – autonomy | 0.033 | 0.09 | ||||
| – relationship | 0.312 | −0.01 | ||||
| – good mood | 0.007 | −0.15 | ||||
| Nakanishi [ | experimental, randomized, cross-sectional | 616 vs. 750 | – interacting with surroundings | QLDJ [ | <0.001 | 0.28 |
| <0.001 | 0.26 | |||||
| – expressing oneself | 0.013 | 0.13 | ||||
| – experiencing minimum negative behaviors | <0.001 | 0.34 | ||||
| – total quality of life | ||||||
| Verbeek [ | quasi-experimental, cross-sectional, longitudinal | 124 vs. 135 | – quality of life | QUALIDEM | 0.076 | 0.00 |
| Te Boekhorst [ | quasi-experimental, longitudinal, matched, cross-sectional | 67 vs. 97 | – quality of life | DQoL [ | n.s. | not available |
| Morgan [ | experimental, cross-sectional | 8 vs. 8 | – awareness and orientation | PEAP [ | <0.05 | 0.22 |
| <0.01 | 0.24 | |||||
| – regulation of stimulation | <0.05 | 0.49 | ||||
| – continuity of the self | ||||||
DQoL = Dementia Quality of Life instrument; PEAP = Professional Environmental Assessment Protocol dimensions; QUALIDEM = Quality of Life Assessment instrument; QLDJ = Quality of Life instrument for Japanese elderly with dementia developed from the Alzheimer's Disease Health-Related Quality of Life (ADRQL); NHQL = Nursing Home Quality of Life scale; n.s. = not significant.
Over time;
domains of the NHQL;
small-scale, homelike SCU/SCU comparison;
small-scale, homelike/n-SCU comparison.